Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

"Crystal Mesh" Book Exposes How Vaginal Mesh Makers Created Medical Devices Of Mass Destruction For Profit At The Expense Of Women's Health And Lives

"Crystal Mesh" provides a cautionary account of how a "profit over people" culture caused catastrophic injuries to many females suffering from pelvic organ prolapse (POP) and stress-urinary incontinence (SUI).


News provided by

Jennifer Banmiller and Alicia Mundy

Dec 19, 2019, 08:00 ET

Share this article

Share toX

Share this article

Share toX


SAN FRANCISCO, Dec. 19, 2019 /PRNewswire-PRWeb/ -- More than 20 years and billions of dollars in profits since their introduction, medical devices designed to treat pelvic organ prolapse (POP) and stress-urinary incontinence (SUI) have condemned women worldwide to death or a debilitating life of chronic pain and injury – leaving most victims without recourse and mesh makers with "lessons learned" and no serious consequences.

SHREDDING MESH'S WALL OF SILENCE ABOUT FLAWED DEVICES &
VICTIMS WITH CATASTROPHIC, OFTEN IRREVERSiBLE, INJURIES

According to Dr. Tom Margolis, “Extirpation of vaginal mesh is akin to taking a hammer and chisel and trying to remove the rebar from a sidewalk while leaving the cement otherwise intact. It is difficult, if not impossible, to remove all the mesh and do it safely."

Post this

In this book, authors Jennifer Banmiller and Alicia Mundy tear down the curtain of secrecy and deceit that enabled device makers to thrive while knowingly mutilating the millions of women who entrusted mesh to help, not harm, them. "Crystal Mesh" raises grave concerns about health care's lack of checks and balances and advises patients to become their own advocates.

"OFF LABEL" SHOULD MEAN "HANDS OFF" UNTIL TESTING

"Crystal Mesh" is a wake-up call. For many years, mesh, which is essentially plastic similar to fishing line, was used in the treatment of hernias. Multinational companies realized they could profit exponentially by commoditizing the vagina and expanding mesh's use to address embarrassing female situations. They positioned a slight drip of urine after laughing as a major issue for childbearing or mature women.

These companies identified a market segment of 13,000,000 baby boomers who would develop incontinence. They then paid medical consultant doctors millions of dollars to promote implantation of mesh worldwide. This brilliant marketing strategy proved immensely profitable by targeting human traits such as insecurity and greed.

TEFLON DONS IN FIGHT AGAINST MESH

For decades, pharmaceutical and medical device makers have funded and lobbied trusted regulatory agencies, medical associations and lawmakers in order to get their products to market, without randomized clinical trials or pre-market authorization, before their competitors can cash in on "new and improved" versions of products once approved and later recalled by the FDA.

Mesh makers need for speed to market left no time for clinical testing on women, despite warnings of potentially deadly side effects from their internal medical experts – making women victims to untested experimental products and surgeries by unskilled doctors in a culture of profit over people.

Sales representatives for medical device manufacturers persuaded doctors to conduct a 30-minute mesh procedure, that was outside their field of expertise, with false promises of safety and simplicity of technique. They recommended a speedy repetition of insertions as the key to mastering the procedure. No one was ever taught how to remove the mesh.

To this day, there is no protocol to remove mesh. According to Dr. Tom Margolis, "Extirpation of vaginal mesh is akin to taking a hammer and chisel and trying to remove the rebar from a sidewalk while leaving the cement otherwise intact and not damaging the water mains and powerlines below. It is difficult, if not impossible, to remove all the mesh and do it safely."

BIG BULLIES, BAD MEDICINE, BIG PROFITS

Bullying by these same mesh makers forced medical associations, who relied on their money, to omit the word "experimental" from bulletins because experimental procedures are not covered by third-party insurance. They did not share horror stories about mesh from around the globe to any U.S. stakeholders – the FDA, medical associations, doctors and, especially, medical consumers – because this information would "kill" their business.

CASHING IN ON WOMEN'S REPRODUCTIVE SYSTEMS

Women continue to suffer punctured bladders, severed urethras, paralyzation and permanent limps due to nerve damage from the rasp-like vaginal mesh that migrates through vaginal walls to damage surrounding organs. Recently, doctors have also linked autoimmune diseases to mesh. As an added bonus, the penises of many victim's partners were slashed by the eroded mesh. Mesh was not only life-changing; it is life-destroying.

These harrowing stories are the human casualties in the rush for companies to sell medical devices based on flawed predicate products already banned by the FDA.

"Crystal Mesh" documents how greed placed profit over health and turned the essence of a woman into a high-worth commodity ripe to yield mind-altering profits. It also provides examples of how other countries and excellent physicians are helping women -- the veterans left behind in the "gold rush" of mesh. Most importantly, this chilling book reminds buyers to beware and patients to advocate for their own rights.

510(k) GOLDEN LOOPHOLE

During the 1990s, government deregulation was designed to stimulate economic prosperity and fast-track innovative products to consumers. Unfortunately, this climate of deregulation set the stage for major crises in the financial, housing and pharmaceutical industries. In the medical device arena, it created a golden loophole for new products to bypass the 510(k) requirements of the Federal Food, Drug, and Cosmetic Act.

If a product could be proved "substantially equivalent" to a device that had been previously "approved" by the FDA's Medical Device Office for marketing, the "new and improved" device could go be sold to the public, even if its predicate product was ultimately "banned" for safety reasons.

Clinical testing, usually performed on pigs, rats and human cadavers, was not required for a product that would be permanently implanted (without a procedure developed to extract it) in women seeking help with prolapse or stress urinary incontinence. For most of the women who developed serious complications, there is no way out. For more information, please visit http://www.crystalmesh.com.
###

SOURCE Jennifer Banmiller and Alicia Mundy

Modal title

Crystal Mesh Quotes
Crystal Mesh Quotes
Crystal Mesh Quotes

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.